Prevalence of Pathogenic Variants and Eligibility Criteria for Genetic Testing in Patients Who Visit a Memory Clinic
Sven J. van der Lee(Amsterdam Neuroscience), Henne Holstege(Amsterdam University Medical Centers), Itziar de Rojas(Instituto de Salud Carlos III), Wiesje M. van der Flier(Amsterdam Neuroscience), Mieke M. van Haelst(University of Amsterdam), Mariet W. Elting(Amsterdam University Medical Centers), Fred van Ruissen(Amsterdam University Medical Centers), Marcel Reinders(Leiden University), Corien C. Verschuuren‐Bemelmans(University Medical Center Groningen), Christa de Geus, Janna I.R. Dijkstra(Amsterdam Neuroscience), Jetske van der Schaar(Amsterdam Neuroscience), Yolande A.L. Pijnenburg(Amsterdam Neuroscience), Marc Hulsman(Amsterdam University Medical Centers), Niccoló Tesi(Amsterdam UMC Location University of Amsterdam), Rosalina van Spaendonk(University Hospital and Clinics)
Cited by 8
Related Papers
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
|Nature Genetics|2019|3.3k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k